1. Adil, A., & Godwin, M. (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 77(1), 136–141.e5. Retrieved from https://pubmed.ncbi.nlm.nih.gov/28396101/
2. Chin E. Y. (2013). Androgenetic alopecia (male pattern hair loss) in the United States: what treatments should primary care providers recommend?. Journal of the American Association of Nurse Practitioners, 25(8), 395–401. Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1111/1745-7599.12030
3. Hillmer, A. M., Hanneken, S., Ritzmann, S., Becker, T., Freudenberg, J., Brockschmidt, F. F., Flaquer, A., Freudenberg-Hua, Y., Jamra, R. A., Metzen, C., Heyn, U., Schweiger, N., Betz, R. C., Blaumeiser, B., Hampe, J., Schreiber, S., Schulze, T. G., Hennies, H. C., Schumacher, J., Propping, P., … Nothen, M. M. (2005). Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American journal of human genetics, 77(1), 140–148. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1226186/
4. Kaiser, M., Abdin, R., Gaumond, S. I., Issa, N. T., & Jimenez, J. J. (2023). Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. Clinical, cosmetic and investigational dermatology, 16, 1387–1406. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239632/
5. Randolph, M., & Tosti, A. (2021). Oral minoxidil treatment for hair loss: A review of efficacy and safety. Journal of the American Academy of Dermatology, 84(3), 737–746. Retrieved from https://pubmed.ncbi.nlm.nih.gov/32622136/
6. Rhodes, T., Girman, C. J., Savin, R. C., Kaufman, K. D., Guo, S., Lilly, F. R., Siervogel, R. M., & Chumlea, W. C. (1998). Prevalence of male pattern hair loss in 18-49 year old men. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 24(12), 1330–1332. Retrieved from https://pubmed.ncbi.nlm.nih.gov/9865198/